why choose us

First received: January 26, 2023

Clinical Trial: Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Heart Failure

Study Type: INTERVENTIONAL


Official Title: A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to S

Brief Summary: This study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline to Week 16.The primary hypothesis is Vericiguat is superior to placebo in reducing NT-proBNP at Week 16.

Read more